HOME >> MEDICINE >> NEWS
Experimental drug reverses effects of Fabry disease in mice

Shows promise for related disorders

ANN ARBOR, 12 June 2000 -- A new experimental drug developed at the University of Michigan Medical School is the first treatment shown to reverse the effects in mice of a hereditary, incurable disorder called Fabry (Fah-BRAY) disease, which affects between 6,000 and 10,000 men in the United States.

Results of the study were published in the June 2000 issue of the Journal of Clinical Investigation in an article by James Shayman, M.D., U-M professor of pharmacology and of internal medicine, and colleagues from the U-M and the National Institutes of Health.

Fabry disease is caused by a genetic mutation that prevents production of an enzyme called alpha-galactosidase A, which cells store in tiny globules called lysosomes. The cellular version of a garbage disposal, lysosomes are found in all cells that use enzymes to dissolve specific molecular bonds and digest waste products.

Without alpha-galactosidase A, lysosomes cannot break up one particular type of glycolipid, a long chain of fats and sugars found in cell membranes. As a result, these molecules accumulate within the kidneys, hearts and blood vessels of patients with Fabry disease. Death occurs in early adulthood from renal failure or cardiovascular complications.

For the past 10 years, U-M researchers have been developing and perfecting a family of glycolipid synthesis inhibitors for use in Fabry disease, according to Shayman. "Other researchers tried to replace the missing enzyme, but we concentrated on blocking glycolipid formation by inhibiting a key enzyme the cell needs to produce these molecules. We now have two compounds with high levels of inhibitory activity and no observed toxic side effects."

According to the Journal of Clinical Investigation study, treatment with one of these compounds produced a highly significant reduction in glycolipid levels in kidneys of male mice with Fabry disease. When treated for eight
'"/>

Contact: Sally Pobojewski
pobo@umich.edu
734-647-1844
University of Michigan
11-Jun-2000


Page: 1 2

Related medicine news :

1. St. Jude scientist wins International Society of Experimental Hematology award
2. Experimental drug improves sleep in older patients, Wake Forest Baptist study shows
3. Experimental drug used to treat recurrent ovarian cancer shows promising results
4. Experimental treatment yields new hope for children battling cerebral palsy
5. Experimental drugs show promise in halting brain tumors
6. Experimental drugs reduce neuron death in rats following insulin shock
7. Experimental pill found to improve symptoms in patients with non-small-cell lung cancer
8. Experimental peptides prevent diabetes and halt its progression
9. Experimental testosterone patch shows promise for treating diminished sexual function in surgically menopausal women
10. Clinical Trial Demonstrates Experimental Growth Factor Increases Eligibility For Autologous Stem Cell Transplantation
11. Antibody treatment partially reverses nerve damage in Alzheimer disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... (PRWEB) , ... July 02, 2020 , ... ... many businesses, including dental offices for non-emergency work. In conjunction with the American ... guidelines for Connecticut dental practices in mid-May. , Due to safety concerns, ...
(Date:7/1/2020)... Fla. (PRWEB) , ... July 01, 2020 , ... ... LLC specializing in the clinical development of psychedelics and analogues, announces its core ... combined experience in natural product drug discovery, novel formulations, and as distinguished researchers ...
(Date:6/28/2020)... ... June 26, 2020 , ... The Pool ... revision and redesignation of the ANSI/APSP/ICC-7 2013 American National Standard for Suction Entrapment ... is seeking member participation on the PHTA-7 Standard Writing Committee (SWC) for Suction ...
(Date:6/28/2020)... ... 26, 2020 , ... Recovery from drug and alcohol addiction ... center, proudly announces that it has reopened to serve new clients with a ... world affected by Covid-19. , When social-distancing guidelines changed the way residential facilities ...
(Date:6/28/2020)... (PRWEB) , ... June 27, 2020 , ... ... Connect Classroom, the first online, full-day educational conference in the organization’s history. The ... for facioscapulohumeral muscular dystrophy (FSHD), which was cancelled this year due to COVID-19. ...
Breaking Medicine News(10 mins):
(Date:7/7/2020)... (PRWEB) , ... July 07, 2020 , ... ... announced its partnership with Psych Hub, the leading comprehensive platform for online education ... Health to offer support resources to Substance Use Disorder (SUD) patients throughout each ...
(Date:7/7/2020)... ... July 07, 2020 , ... ... to Navajo Nation residents, the 33 nonprofits who received the latest ISA ... fourth round of funding, the foundation awarded grants totaling $838,527 to the U.S.-based ...
(Date:7/4/2020)... ... July 03, 2020 , ... ... began to welcome visitors at approved capacities, reactivating the state's economy. The government ... other preventive actions. , The most recent opening was beautiful Hacienda Tres Ríos ...
Breaking Medicine Technology:
Cached News: